Work Here?
Industries
Fintech
Biotechnology
Healthcare
Company Size
501-1,000
Company Stage
IPO
Headquarters
Nashville, Tennessee
Founded
1999
Revance Therapeutics focuses on biotechnology solutions in the aesthetics market, offering products that enhance physical appearance and improve patient outcomes. Their main products include neuromodulators, like botulinum toxin type A, which reduce wrinkles and treat muscle movement disorders, and dermal fillers that restore volume and smooth facial lines. Revance also explores therapeutic uses for its products in treating muscle movement and pain disorders. A unique aspect of Revance is its expansion into the fintech sector with the acquisition of HintMD, which streamlines payment processes for aesthetic practices. This integration allows Revance to provide a comprehensive suite of services to support aesthetic practitioners. The company aims to lead the premium aesthetics market by focusing on differentiated products and improved patient experiences.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$2485M
Above
Industry Average
Funded Over
9 Rounds
Health Insurance
Unlimited Paid Time Off
401(k) Company Match
Professional Development Budget
Revance, a fast-growing global leader in aesthetics and skincare, has announced a leadership transition to support the companys next chapter of growth and innovation, as it builds toward becoming the... The post Revance announces leadership transition appeared first on Teknovation.biz.
NASHVILLE, Tenn., May 27, 2025 /PRNewswire/ -- Revance is proud to announce that Blue Lizard® Australian Sunscreen, the #1 best-selling mineral SPF brand in the U.S.*, is celebrating National Sunscreen Day on May 27th with a dynamic digital billboard in New York City's Times Square, capping off Skin Cancer Awareness Month and heading into sun season with a bold message: Be Fearless in the Sun
Revance Therapeutics has announced a leadership succession plan, with founder and CEO Jeff Bedard transitioning to the role of Executive Chairman and Nadeem Moiz, the current President and CFO, appointed as the incoming Chief Executive Officer.
NASHVILLE, Tenn., May 21, 2025 /CNW/ - Revance is proud to announce that Blue Lizard Australian Sunscreen(R) is partnering with The Bentway's Summer 2025 Sun/Shade program, a dynamic celebration of arts, culture, and community hosted in one of Toronto's most iconic public spaces: beneath the Gardiner Expressway.
NASHVILLE, Tenn., May 1, 2025 /PRNewswire/ -- Revance is thrilled to announce that Blue Lizard® Australian Sunscreen, a leader in mineral sun protection, is now the number one Selling Mineral Sunscreen Brand*. This exciting milestone reflects the growing consumer demand for high-performing, dermatologist-recommended sun protection that's both effective and gentle on sensitive skin
Find jobs on Simplify and start your career today
Industries
Fintech
Biotechnology
Healthcare
Company Size
501-1,000
Company Stage
IPO
Headquarters
Nashville, Tennessee
Founded
1999
Find jobs on Simplify and start your career today